PMU67 - COST-EFFECTIVENESS ANALYSIS OF IXEKIZUMAB VERSUS SECUKINUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS AND CONCOMITANT MODERATE-TO-SEVERE PSORIASIS IN THE UNITED KINGDOM
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.1903
https://www.valueinhealthjournal.com/article/S1098-3015(18)35205-7/fulltext
Title :
PMU67 - COST-EFFECTIVENESS ANALYSIS OF IXEKIZUMAB VERSUS SECUKINUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS AND CONCOMITANT MODERATE-TO-SEVERE PSORIASIS IN THE UNITED KINGDOM
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35205-7&doi=10.1016/j.jval.2018.09.1903
First page :
Section Title :
Open access? :
No
Section Order :
1267